This market research report is available for purchase below. It provides an overview of the current market dynamics in the small molecule sterile injectable manufacturing space, as well as what our survey respondents—all outsourcing decision-makers—predict the market will look like in 2022. Key statistics include development-stage and marketed product volume, the proportion outsourced, and the number of CMOs required to complete the work. ISR explores the therapeutic categories and delivery devices in drug innovators’ pipelines and portfolios, how likely manufacturing is to be outsourced by these categories, and how these proportions will shift over the next five years. You can purchase a single-user license for individual use, a site-wide license giving access to the report for all employees within a single site/office location, or an enterprise-wide license giving access to all employees within your organization. You can also download a free preview file below.
Learn more by downloading the free preview file, or by purchasing the full report below.